10 to 11 am ET

12 to 1 pm BRT

Cisco Webex
Online

Share

(AdobeStock)

COVID-19 and the Transformation of Digital Medicine in Brazil

Healthcare experts from the public and private sectors will discuss how best to use new technologies to improve access to healthcare and quality of care.

10 to 11 am ET

12 to 1 pm BRT

Cisco Webex
Online

Share

(AdobeStock)

Overview

COVID-19 transformed medicine in Brazil. The country has moved from a ban on virtual patient appointments to an environment in which many aspects of a healthcare provider’s work are conducted remotely. Medicine and medical appointments have adapted to the digital world. More people were taken care of, more quickly and with greater safety. The use of telemedicine is part of the process of modernizing Brazilian medicine, contributing to an increase in appointments and taking medicine to places where it did not yet exist. In the midst of the COVID-19 pandemic, public and private health systems have found an opportunity to take the leap into the future. However, there is still a lot of room for growth. At the end of 2020, the law that allowed virtual appointments will expire. What are the risks of not being able to utilize telemedicine anymore? What other advances in digital health does Brazil need? How can we use these new technologies to expand patient access to health services and promote better results? In this panel we will discuss these and other issues related to technology and medicine. The conversation will be held in Portuguese.

COVID-19 e a Transformação Digital da Medicina no Brasil

A COVID-19 transformou a medicina no Brasil. O país passou de uma proibição de consultas virtuais a pacientes a um ambiente no qual muitos aspectos do trabalho de um provedor de saúde passaram a ser realizados remotamente. A medicina e as consultas médicas se adaptaram ao mundo digital. Mais pessoas foram atendidas, com mais celeridade e com maior segurança. O uso da telemedicina faz parte do processo de modernização da medicina no Brasil, contribuindo para a expansão do número de atendimentos e levando a medicina para lugares onde ela ainda não existia. Em meio à crise decorrente da pandemia do Coronavírus, os sistemas de saúde público e particular encontraram uma oportunidade para dar o salto ao futuro. No entanto, ainda há muito espaço para evoluirmos. No fim do ano de 2020 a lei que permitiu consultas virtuais expirará. Quais são os riscos de não mais podermos contar com o uso da telemedicina? Que outros avanços em saúde digital o Brasil necessita? Como podemos usar essas novas tecnologias para expandir o acesso de pacientes a serviços de saúde e promover melhores resultados? Nesse painel discutiremos essas e outras questões relacionadas à tecnologia e a à medicina. O painel será conduzido em português.

Panelists:

  • Hiran Gonçalves, Federal Deputy
  • Jihan Zoghbi, CEO, Dr. TIS
  • Shirley Meschke, Director of Legal Division for Brazil and Legal Lead in South Latin America, Pfizer
  • José Cechin, Executive Superintendent, Institute of Supplementary Health Studies (IESS) (moderator)

This event is part of the AS/COA Healthcare series.


Event Information: Marcelo Barreta | Mbarreta@as-coa.org | 1-212-277-8378
Sponsorship Opportunities: Ana Calderon | acalderon@as-coa.org | 1-212-277-8358
Individual Membership Information: Lee Evans | levans@as-coa.org | 1-212-277-8384
COA Corporate Membership: Mila Fontana | mfontana@as-coa.org | 1-212-277-8331
Press Inquiries: mediarelations@as-coa.org

View a list of COA corporate members.

Speakers

Hiran Gonçalves
Federal Deputy

Hiran Gonçalves was born in the city of Tefé, in the state of Amazonas and graduated with a degree in medicine from the Federal University of Amazonas. He moved to Roraima in 1982, where he developed his career. For over 25 years he worked as a coroner at the Instituto Médico...

SEE MORE
Jihan Zoghbi
CEO, Dr. TIS

Jihan Zoghbi is CEO and founder Dr. TIS, president of ABCIS and CIO Ameplan Saúde. She holds a bachelor's degree in computer science from Universidade Presbiteriana Mackenzie (2002), master's in computer science from USP (2011) and PhD in computer science from USP (2016). She has...

SEE MORE
Shirley Meschke
Director of Legal Division for Brazil and Legal Lead in South Latin America, Pfizer

Shirley Meschke Mendes Franklin de Oliveira joined Pfizer in 2006 and holds the position of director of legal division for Brazil and legal lead in South Latin America. She also performed other roles in Pfizer, as compliance officer, global product counsel of rare disease...

SEE MORE
José Checin
Executive Superintendent, Institute for Supplementary Health Studies (IESS)

José Cechin is executive superintendent of the Institute for Supplementary Health Studies (IESS). He was minister of social security in the Fernando Henrique Cardoso administration and executive director of the National Supplementary Health Federation (FenaSaúde). He is an...

SEE MORE
Corporate Sponsor
Healthcare Series Sponsors